Chan Chun-Yiu Oliver, Yau Kwok-Kay Kevin, Siu Wing-Tai, Wong Kin-Hung Simon, Luk Yiu-Wing, Tai Tai Yuk-Ping, Li Ka-Wah Michael
Hong Kong, China.
Gastrointest Endosc. 2008 Jan;67(1):35-9. doi: 10.1016/j.gie.2007.05.042. Epub 2007 Oct 22.
The feasibility, efficacy, and safety of the TriClip in the management of peptic ulcer hemorrhage in human beings are scarcely reported in the literature.
A pilot study was conducted to assess the feasibility, efficacy, and safety of the TriClip endoscopic clipping device in the control of peptic ulcer hemorrhage.
Prospective evaluation.
Regional government hospital.
From July 2004 to January 2005, patients older than 16 years and with Forrest type I and IIa peptic ulcer hemorrhages were included in the study.
TriClips were used for initial hemostasis. Salvage procedures, including adrenalin injection, heat probe application, argon plasma coagulation, or surgery will be carried out appropriately if TriClip failed to control bleeding alone. An endoscopy was repeated 24 hours later for the security of the TriClip and for any endoscopic evidence of recurrent bleeding. A follow-up endoscopy was performed 8 weeks later to assess ulcer healing.
Procedure time, successful hemostatic rate, number of clips used, ulcer recurrent bleeding rate, complications, and ulcer healing rate were measured.
No comparative arm; pilot study only.
A total of 27 cases (11 women, 16 men) were included in the study, with a median age of 70 years (range 18-88 years). There were 19 cases of duodenal ulcer and 8 cases of gastric ulcer, with median size of 8 mm (range 2-20 mm). The rate of successful hemostasis in the first endoscopy by TriClips alone was 81.5% (22/27), with a median procedure time of 10 minutes (range 3-30 minutes). In the second endoscopy, the endoscopic recurrent bleeding rate was 14.8% (4/27) and the TriClips were found dislodged in 11 patients (40.7%). The permanent hemostasis rate was 67% (18/27). The overall failure rate was 33% (9/27). Three patients required blood transfusion before the first endoscopy. There was no morbidity or mortality observed in all cases. All ulcers healed after 8 weeks.
The use of the TriClip is feasible in the initial control of peptic ulcer hemorrhage. However, we could not detect any obvious advantages in arresting bleeding vessels by using this new clipping device.
文献中鲜有关于TriClip在人类消化性溃疡出血治疗中的可行性、有效性和安全性的报道。
进行一项前瞻性研究,以评估TriClip内镜夹闭装置控制消化性溃疡出血的可行性、有效性和安全性。
前瞻性评估。
地区政府医院。
2004年7月至2005年1月,年龄大于16岁且患有Forrest I型和IIa型消化性溃疡出血的患者被纳入研究。
使用TriClip进行初始止血。如果TriClip单独未能控制出血,则适当进行挽救性操作,包括肾上腺素注射、热探头应用、氩离子凝固术或手术。24小时后重复进行内镜检查,以确保TriClip的安全性以及有无复发出血的内镜证据。8周后进行随访内镜检查以评估溃疡愈合情况。
测量操作时间、成功止血率、使用夹子数量、溃疡复发出血率、并发症和溃疡愈合率。
无对照臂;仅为初步研究。
共纳入27例患者(11例女性,16例男性),中位年龄70岁(范围18 - 88岁)。十二指肠溃疡19例,胃溃疡8例,中位大小为8mm(范围2 - 20mm)。仅使用TriClip进行首次内镜检查时的成功止血率为81.5%(22/27),中位操作时间为10分钟(范围3 - 30分钟)。在第二次内镜检查中,内镜复发出血率为14.8%(4/27),发现11例患者(40.7%)的TriClip移位。永久止血率为67%(18/27)。总体失败率为33%(9/27)。3例患者在首次内镜检查前需要输血。所有病例均未观察到并发症或死亡。8周后所有溃疡均愈合。
TriClip在消化性溃疡出血的初始控制中是可行的。然而,我们未发现使用这种新型夹闭装置在止血方面有任何明显优势。